Underexpression of C-myc in adrenocortical cancer: A major pathogenic event?

Hormone and Metabolic Research

Volumn 43, Issue 5, 2011, Pages 297-299

  Szabo P M ^a   Racz K ^a   Igaz, P ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

adrenal; meta analysis; network; tumour

Indexed keywords

CORTICOTROPIN; FIBROBLAST GROWTH FACTOR; MESSENGER RNA;

ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX CELL; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME 8Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE EXPRESSION; GENE UNDEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE C MYC; PRIORITY JOURNAL; REVIEW;

ADRENAL CORTEX NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 79955690969     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0031-1273762     Document Type: Review

References (21)

1. Soucek L, Evan GI. The ups and downs of Myc biology. Curr Opin Genetics Dev 2010; 20: 91-95
2. Nesbit CE, Tersak JM, Prochownik EV. MYC oncogenes and human neoplastic disease. Oncogene 1999; 18: 3004-3016 (Pubitemid 29276540)
3. Szabó PM, Tamási V, Molnár V, Andrásfalvy M, Tömböl Z, Farkas R, Kövesdi K, Patócs A, Tóth M, Szalai C, Falus A, Rácz K, Igaz P. Metaanalysis of adrenocortical tumor genomics data: novel pathogenic pathways revealed. Oncogene 2010; 29: 3163-3172
4. Giordano TJ, Kuick R, Else T, Gauger PG, Vinco M, Bauersfeld J, Sanders D, Thomas DG, Doherty G, Hammer G. Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin Cancer Res 2009; 15: 668-676
5. de Reyniès A, Assié G, Rickman DS, Tissier F, Groussin L, René-Corail F, Dousset B, Bertagna X, Clauser E, Bertherat J. Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. J Clin Oncol 2009; 27: 1108-1115
6. Tömböl Z, Szabó PM, Molná r V, Wiener Z, Tölgyesi G, Horányi J, Riesz P, Reismann P, Patócs A, Likó I, Gaillard RC, Falus A, Rácz K, Igaz P. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. Endocr Relat Cancer. 2009; 16: 895-906
7. Barabasi AL, Albert R. Emergence of scaling in random networks. Science 1999; 286: 509-512
8. Crucitti, Latora V, Marchiori M. Model for cascading failures in complex networks. Phys Rev 2004; E 69: 045104-1-045104-4
9. Liu J, Voutilainen R, Kahri AI, Heikkilä P. Expression patterns of the c-myc gene in adrenocortical tumors and pheochromocytomas. J Endocrinol 1997; 152: 175-181 (Pubitemid 27115766)
10. Heikkilä P, Arola J, Salmi A, Kahri AI. ACTH-induced c-myc protononcogene expression precedes antimitogenic effect during differentiation of fetal rat adrenocortical cells. J Endocrinol 1995; 145: 379-385
11. Liu J, Voutilainen R, Kahri AI, Heikkilä P. Expression of the c-myc gene in human adrenals: regulation by adrenocorticotropin in primary cultures. J Endocrinol 1996; 148: 523-529 (Pubitemid 26101567)
12. Coulter CL. Fetal adrenal development: insight gained from adrenal tumors. Trends Endocrinol Metab 2005; 16: 235-242 (Pubitemid 40853887)
13. Larsson LS, Henriksson MA. The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy. Exp Cell Res 2010; 316: 1429-1437
14. Gandarillas A, Watt FM. c-Myc promotes differentiation of human epidermal stem cells. Genes Dev 1997; 11: 2869-2882 (Pubitemid 27481687)
15. Bettess MD, Dubois N, Murphy MJ, Dubey C, Roger C, Robine S, Trumpp A. c-Myc is required for the formation of intestinal crypts but dispensable for homeostasis of the adult intestinal epithelium. Mol Cell Biol 2005; 25: 7868-7878 (Pubitemid 41170145)
16. Toftgard R, Roop DR, Yuspa SH. Proto-oncogene expression during two-stage carcinogenesis in mouse skin. Carcinogenesis 1985; 6: 655-657 (Pubitemid 15101803)
17. Watson JV, Stewart J, Evan GI, Ritson A, Sikora K. The clinical significance of flow cytometric c-myc oncoprotein quantitation in testicular cancer. Br J Cancer 1986; 53: 331-337 (Pubitemid 16133102)
18. Fassnacht M, Allolio B. Clinical management of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab 2009; 23: 273-289
19. Lepique AP, Moraes Ms, Rocha KM, Eichler CB, Hajj GNM, Schwindt TT, Armelin HA. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells. J Mol Endocrinol 2004; 33: 623-638 (Pubitemid 40057558)
20. Baudino TA, McKay C, Pendeville-Samain H, Nilsson JA, Maclean KH, White EL, Davis AC, Ihle JN, Cleveland JL. c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev 2002; 16: 2530-2543
21. Bernini GP, Moretti A, Bonadio AG, Menicagli M, Viacava P, Naccarato AG, Iacconi P, Miccoli P, Salvetti A. Angiogenesis in human normal and pathologic adrenal cortex. J Clin Endocrinol Metab 2002; 87: 4961-4965 (Pubitemid 35316333)